With a new administration and fresh leadership at the USPTO, the life sciences intellectual property landscape is poised for change. This panel will explore key developments in life sciences IP, from pending legislation to evolving policies on patent enforcement and government intervention. Discussion topics include:

• The new USPTO Director’s approach: Will patent protections strengthen or weaken under new leadership?
• What legislative reforms could reshape patent rights and innovation incentives?
• Updates on the PREVAIL Act, RESTORE Act, PERA, and other pending IP reforms
• The future of march-in rights: Will the government expand its ability to override life sciences patents?
• Broader patent law trends and what life sciences companies should anticipate in the coming years